Carl P. Sherr & Co’s AbbVie ABBV Stock Holding History

Carl P. Sherr & Co’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.17M	Hold	4,653	–	–	0.49%	43
2026 Q1	$1.01M	Hold	4,653	–	–	0.48%	47
2025 Q4	$1.04M	Hold	4,653	–	–	0.46%	44
2025 Q3	$1.08M	Buy	4,653 +50	+1%	+$10.2K	0.51%	43
2025 Q2	$854K	Sell	4,603 -250	-5%	-$46.5K	0.43%	47
2025 Q1	$1.02M	Hold	4,853	–	–	0.56%	42
2024 Q4	$862K	Hold	4,853	–	–	0.45%	48
2024 Q3	$958K	Hold	4,853	–	–	0.5%	45
2024 Q2	$832K	Sell	4,853 -417	-8%	-$69.1K	0.46%	50
2024 Q1	$960K	Hold	5,270	–	–	0.54%	47
2023 Q4	$817K	Sell	5,270 -200	-4%	-$29.2K	0.49%	52
2023 Q3	$815K	Hold	5,470	–	–	0.55%	51
2023 Q2	$737K	Hold	5,470	–	–	0.48%	53
2023 Q1	$872K	Hold	5,470	–	–	0.62%	39
2022 Q4	$884K	Sell	5,470 -4	-0.1%	-$613	0.67%	43
2022 Q3	$735K	Buy	5,474 +721	+15%	+$103K	0.59%	45
2022 Q2	$728K	Buy	4,753 +350	+8%	+$53.5K	0.54%	50
2022 Q1	$714K	Sell	4,403 -350	-7%	-$50.8K	0.48%	59
2021 Q4	$644K	Buy	4,753 +285	+6%	+$33.7K	0.39%	67
2021 Q3	$482K	Hold	4,468	–	–	0.38%	60
2021 Q2	$503K	Hold	4,468	–	–	0.35%	68
2021 Q1	$484K	Sell	4,468 -21	-0.5%	-$2.25K	0.36%	67
2020 Q4	$481K	Buy	4,489 +21	+0.5%	+$2.02K	0.38%	72
2020 Q3	$391K	Hold	4,468	–	–	0.35%	74
2020 Q2	$439K	Hold	4,468	–	–	0.44%	73
2020 Q1	$340K	Buy	4,468 +75	+2%	+$6.39K	0.4%	76
2019 Q4	$389K	Buy	+4,393	New	+$365K	0.38%	78

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Carl P. Sherr & Co's ABBV Position: Q2 2026 in Review

Carl P. Sherr & Co held its AbbVie (ABBV) position steady in Q2 2026 at 4,653 shares worth $1.17M. The position accounts for 0.49% of the portfolio, ranked #43.

Carl P. Sherr & Co first reported a position in ABBV in Q4 2019 and has held it in 27 quarters since. 4,224 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Carl P. Sherr & Co held 4,653 shares of AbbVie worth $1.17M as of Q2 2026.
Carl P. Sherr & Co left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.49% of Carl P. Sherr & Co's portfolio in Q2 2026, its #43 holding.
Carl P. Sherr & Co first reported a position in AbbVie in Q4 2019 and has held it in 27 quarters since.
4,224 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Carl P. Sherr & Co's 13F filing for Q2 2026, filed 3 Aug 2026.